US2005239726A1PendingUtilityA1

Novel nucleosides and related processes, pharmaceutical compositions and methods

Assignee: UNIV YALEPriority: Dec 17, 2002Filed: Jun 30, 2005Published: Oct 27, 2005
Est. expiryDec 17, 2022(expired)· nominal 20-yr term from priority
C07H 19/22
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides novel nucleosides and related processes, pharmaceutical compositions, and methods. The novel nucleosides are useful in a wide variety of antiviral, antineoplastic, and antibacterial applications. Preferred embodiments of the instant invention include novel 2 halogen-substituted, 3 halogen-substituted, and 2′,3′dihalogen-substituted analogues of 3-deazaadenosine, and novel 3 halogen-substituted analogues of 3-deazaguanosine. Compounds of the instant invention, including 4-Amino-6-fluoro-1-(β-D-ribofuranosyl)imidazo[4,5-c]pyridine and 6-Amino-7-bromo-1,5-dihydro-1-β- D -ribofuranosylimidazo[4,5-c]pyridin-4-one, have exhibited potent antiviral and anticancer activity in vitro. The compounds are also useful in the concomitant treatment of bacterial infections associated with viral infections such as AIDS.

Claims

exact text as granted — not AI-modified
1 - 59 . (canceled)  
   
   
       60 . A method of treating tuberculosis in a patient in need thereof comprising administering to said patient an effective amount of a compound according to the formula:  
     
       
         
         
             
             
         
       
     
     or its pharmaceutically acceptable salt, optionally in combination with a pharmaceutically acceptable carrier additive or excipient.

Join the waitlist — get patent alerts

Track US2005239726A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.